Main Menu

Target Validation and DNA Damage Response Team

Professor Tutt’s team interests involve the discovery of novel therapies and biomarkers in BRCA1/BRCA2-associated cancers and ER/HER2-negative/basal-like breast cancers – including the identification of new drug targets and therapy combination strategies.

Team leader

Professor Andrew Tutt

Professor Andrew Tutt

Director, Breast Cancer Now Toby Robins Research Centre

Andrew Tutt is Head of the Division of Breast Cancer Research and Director of the Breast Cancer Now Toby Robins Research Centre at the ICR and Guy’s Hospital King’s College London. He is a Clinician Scientist with the Laboratory and Clinical Trials programme, and a Consultant Clinical Oncologist looking after women with breast cancer.

ORCID 0000-0001-8715-2901

Team members

Dr Valeria Amodeo

Senior Scientific Officer +44 20 3437 6128

Dr Kathryn Davidson

Honorary Appointment

Dr Riccardo Ferro

Research Associate +44 20 3437 7039

Luke Hitchen

Honorary Appointment

Helen Kakkassery

Honorary Appointment

Dr Gabriel Kollarovic

Higher Scientific Officer +44 20 7153 5452

Dr Rebecca Marlow

Honorary Appointment

Alexia Martin

PhD Student +44 20 7153 5277

Blanca Navarro

Honorary Appointment

Dr Maya Raghunandan

Postdoctoral Training Fellow +44 20 7153 5423

Thomas Savy

Scientific Officer +44 20 3437 7077

Dr Ramsay Singer

Clinical Research Fellow

Dr Gonzalo Torga

Clinical Scientist +44 20 7153 5497

Dr Callum Walker

Honorary Appointment

Dr Daniel Weekes

Senior Scientific Officer

Dr Amadeus Xu

Higher Scientific Officer +44 20 3437 6048

Dr Jason Yeung

Clinical Research Fellow +44 20 7153 5444